APMRS ’23

Venue

The conference will take place in the Center for Chemistry and Biomedicine (CCB) on Campus Innrain of the Leopold-Franzens-University Innsbruck.

Leopold-Franzens Universität Innsbruck
Centrum für Chemie und Biomedizin
Innrain 80-82
A-6020 Innsbruck

Registration & Abstract Submission

• Registration is open now!
• Free of charge for APMA members.
• Non-APMA members: 50 €
• Abstract submission deadline: 31.August 2023
• We highly encourage Master / PhD students and young researchers to submit.
• All selected contributions will be presented as oral presentations (10 minutes) or in a poster format

Professor Ole N. Jensen at SDU, Odense, Denmark studies proteins and proteomes to reveal regulatory features, focusing on post-translational modifications (PTMs). He uses mass spectrometry and ion mobility spectrometry to investigate histone proteins and their PTMs in the context of chromatin biology, epigenetics and cancer.

Frank Klont obtained his Pharmacy degree at the University of Groningen where he subsequently also conducted his PhD studies on targeted protein analysis under supervision of Prof. Rainer Bischoff. Next, he joined the Hopfgartner group at the University of Geneva where he gained experience in untargeted metabolomics, in particularly focusing on the identification of xenobiotics and the profiling of (real-world) drug metabolites in population-based studies. In 2022, he returned to Groningen to start as an assistant professor in personalized pharmacotherapy working both at the Groningen Research Institute of Groningen and the hospital pharmacy department of the University Medical Center Groningen. His position is aimed at the integration of a patient’s clinical profile, biomarker status, co-medication, genetic makeup, and (pharmaco)metabolomic profile with the goal to contribute to further personalization of drug treatments

Anneli Kruve graduated in 2011 from the University of Tartu and continued her studies as a post-doc in Technion, Israel. Anneli Kruve was a Humboldt fellow at Freie Universität Berlin (2017–2018). In 2019 Kruve joined Stockholm University and she is in charge of the mass spectrometry laboratory at Stockholm University. Anneli Kruve was selected in 2018 to be among the Top 40 under 40 power list by the Analytical Scientist. Her field of study is the fundamentals and applications of mass spectrometry. Specifically, her group uses modelling and machine learning to understand ionization processes in electrospray, unravel the quantification, structural assignment and toxicity assessment challenges in environmental non-targeted screening. Her group has developed machine learning models to predict the ionization efficiency of compounds in electrospray, which can be further used to quantify the contaminants detected with non-targeted LC/HRMS even if analytical standards are not available. Recently, her group has started exploring the possibility to use empirical analytical information to quantify and assess the toxicity of chemicals detected with mass spectrometry. The research group of Kruve is also investigating the structural characterization of small with high-resolution ion mobility.

Kathrin Breuker is an Associate Professor at the University of Innsbruck, Austria, where her research group uses a special type of mass spectrometer (FT-ICR MS, Fourier transform-ion cyclotron resonance mass spectrometer) for the study of larger biomolecules with focus on ribonucleic acids (RNA). The group is interested in the structure, folding, interactions, and reactivity of RNA in the gas and condensed phases, and develops new approaches for RNA characterization, including the localization of modification and binding sites.

Monika Cziferszky earned her PhD in polymer chemistry under Prof. Robert Liska from the Vienna University of Technology in 2008 before moving for a postdoctoral stay to the University of Cambridge to delve into supramolecular chemistry in the group of Prof. Oren Scherman. There, she developed a keen interest in using mass spectrometry to answer various research questions. Upon her return to Austria, she entered the field of bioinorganic chemistry during a postdoctoral stay with Prof. Ronald Gust at the University of Innsbruck. In 2019, she was appointed as an Assistant Professor at the University of Innsbruck. Lately, she has focused on using mass spectrometry to delineate the modes-of-action of metal-based drugs.

Markus A. Keller is an expert for lipid metabolism with a special focus on inborn metabolic diseases. He started to gain his expertise in his PhD where he dedicated his work to understand the molecular mechanisms of inherited metabolic disorders. At the University of Cambridge, he deepened his knowledge by investigating the enzymology and properties of the lipid metabolic network. Employing advanced LC-MS/MS techniques and bioinformatic strategies, he unravels complex regulatory mechanisms of lipid metabolism. Building upon his expertise, Markus A. Keller established a Biochemical Genetics research group at the Medical University of Innsbruck, where he also heads an ISO15189 accredited laboratory focusing on diagnosis and therapy monitoring of metabolic diseases.

Andreas Koeberle is the Head of the Michael Popp Institute and Full Professor at the University of Innsbruck. His research is located at the interface of inflammation, cancer, and metabolic disease and aims at setting the molecular foundation for the development of phytomedicine in interdisciplinary collaboration. Main areas of expertise are bioactive lipids, their biosynthesis and regulation, as well as strategies for therapeutic intervention. His group uses cutting-edge chromatographic and mass spectrometric methods for targeted lipid bioanalytics (lipidomics), which provides access to the manifold, widely unexplored interrelations between lipid metabolism and signal transduction.